Laboratoiros Quimpharma, s.a. de c.v.

What Laboratoiros Quimpharma, s.a. de c.v. does

Laboratorios Quimpharma, S.A. de C.V. is a privately held Mexican pharmaceutical laboratory founded in 2004 and headquartered in Mexico City. The company develops, manufactures, distributes, and commercializes pharmaceutical products, nutritional supplements, and dermocosmetics for human use, operating through two production plants: one pharmaceutical facility with lines for liquids (suspensions, syrups, solutions) and solids (capsules, tablets, powders), and a specialized plant for dietary supplements and cosmetic products. Quality control is overseen by a dedicated Quality Unit staffed by trained personnel.

The product portfolio spans four categories: prescription drugs (antihistamines, analgesics, antiparasitics, anesthetics, glucocorticoids, and others under brands such as GUAXOQUIM, HISTAPHARM, KALEQUIM, and MITAFAR), OTC products (notably the NORATOQUIM Vitamin C line and FIDOIN-Q pediatric ibuprofen), dermocosmetics (the QUIMODERM moisturizing line including baby, fresh, and diabetic variants), and nutritional supplements (QUIMPAPHIL B12 and a C/D/A vitamin solution). Numerous products hold individual SSA regulatory registrations issued between 2015 and 2024.

The business model is product sales through national distribution: Quimpharma sells principally to major generic pharmacy chains, pharmacy chains, and medication distributors across Mexico, complemented by direct sales and promotional outreach to healthcare professionals for prescription products. The company is 100% Mexican-owned, employs approximately 18 people, and has publicly expressed openness to forming strategic alliances with international laboratories for export opportunities.

Name

Laboratoiros Quimpharma, s.a. de c.v.

Legal name

LABORATORIOS QUIMPHARMA S.A. DE C.V.

Website

https://quimpharma.com.mx

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Laboratorios Quimpharma is a privately held Mexican pharmaceutical laboratory founded in 2004 that develops, manufactures, and distributes prescription drugs, OTC products, nutritional supplements, and dermocosmetics across Mexico through pharmacy chains and distributors.

Ownership category

akta.pro rank

Headquarters

HQ city

Ciudad de México

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products Sales: Development, manufacturing, and commercialization of prescription drugs, OTC medications, dietary supplements, and dermocosmetics through national pharmacy distribution networks.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Laboratorios Quimpharma is a 100% Mexican pharmaceutical laboratory that develops, manufactures, distributes, and commercializes prescription drugs, OTC medications, nutritional supplements, and dermocosmetics for human use. The company operates two production plants with advanced lines for liquid filling (suspensions, syrups, solutions) and solid dosage manufacturing (capsules, tablets, powders), plus a specialized plant for supplements and cosmetics. Products are sold nationally through major pharmacy chains, medical distributors, and direct sales to healthcare professionals.

Product overview

Laboratorios Quimpharma is a 100% Mexican pharmaceutical laboratory developing, manufacturing, distributing, and commercializing pharmaceutical products, nutritional supplements, and dermocosmetics for human use. The company operates two pharmaceutical production plants with advanced production lines: one for liquids (suspensions, syrups, solutions) and another for solids (capsules, tablets, powders), plus a specialized plant for nutritional supplements and cosmetic products. The product portfolio spans four main categories: (1) Prescription products including antihistamines, analgesics, antipyretics, antiparasitics, local anesthetics, ophthalmic products, glucocorticoids, antianemics, laxatives, antispasmodics, nootropics, mucolytics, antitussives, and anti-inflammatories marketed under brands like GUAXOQUIM, HISTAPHARM, KALEQUIM, MITAFAR, PHARMACAINE, RANDOMIXAL, QUIMAFRON, QUIMISTREN, QUIMTULAC, QUIMURAL, QUIMTUSINE, ESCADROX, DROSEQUIM, and QUIMUNEX; (2) OTC products including vitamin C supplements (NORATOQUIM line), cold/flu syrups (GUAXOQUIM), and pediatric ibuprofen (FIDOIN-Q); (3) Dermocosmetics including the QUIMODERM line of moisturizing creams (QUIMODERM, QUIMODERM BABY, QUIMODERM FRESH, QUIMODERM DIAB); and (4) Nutritional supplements including B12 (QUIMPAPHIL) and multivitamin solutions (VITAMINAS C, D y A).

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription Pharmaceuticals (Línea de Prescripción) Branded prescription product line including antihistamines (HISTAPHARM with Desloratadina), analgesics/antipyretics (KALEQUIM with Tramadol/Paracetamol), antiparasitics (MITAFAR with Nitazoxanida), local anesthetics (PHARMACAINE with Lidocaína), ophthalmic products (RANDOMIXAL with Travoprost), allergic rhinitis treatments (QUIMAFRON with Mometasona), antianemics (QUIMISTREN with Hierro/Ácido Fólico), laxatives (QUIMTULAC with Lactulosa), antispasmodics (QUIMURAL with Tolterodina), glucocorticoids (QUIMTUSINE with Budesonida), nootropics (ESCADROX with Piracetam), mucolytics/antitussives (DROSEQUIM Adulto and Infantil with Dropropizina/Bromhexina), anti-inflammatories (QUIMUNEX with Prednisolona), and expectorants/antitussives (GUAXOQUIM with Guaifenesina/Oxolamina). Marketed to healthcare professionals for prescribing.
• OTC Pharmaceuticals (Línea OTC) Over-the-counter product line including GUAXOQUIM expectorant/antitussive syrup (Guaifenesina 2g/Oxolamina 1g per 100mL, 140mL bottle), the NORATOQUIM Vitamin C line (ascorbic acid in drops, chewable tablets, 500mg tablets, 1g effervescent tablets, and 2g tablets), and the FIDOIN-Q pediatric ibuprofen line (40mg/mL pediatric drops and 2g/100mL infant suspension). Sold directly to consumers through pharmacy chains and distributors in Mexico.
• QUIMODERM Dermocosmetics Line Dermocosmetic body moisturizing cream line including QUIMODERM (all skin types with sweet almond oil and calcium hydroxide, 225ml), QUIMODERM BABY (paraben-free baby moisturizer with sweet almond oil), QUIMODERM FRESH (with menthol and calcium hydroxide for relaxing/refreshing effect and muscle pain relief), and QUIMODERM DIAB (formulated for diabetics with sweet almond oil, green tea extract, allantoin, camphor, menthol, and calcium hydroxide for extremely dry skin). Marketed for skin care and hydration.
• Nutritional Supplements (Suplementos Alimenticios) Nutritional supplement line including QUIMPAPHIL Vitamin B12 supplement (boxes of 10 ampoules, 5mL each, and a bonus pack of 2 boxes) and VITAMINAS C, D y A solution supplement (250,000mg Vitamin C, 0.010mg Vitamin D, and 15,000mg Vitamin A per ampoule, 3mL ampoules in boxes of 5). Manufactured in the specialized supplement plant and sold through pharmacy distribution.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• International Laboratories (unspecified)minorStrategic or Co-development PartnerQuimpharma is open to forging strategic alliances with international laboratories to grow together and conquer new market niches. They are exploring export opportunities through partnerships with international pharmaceutical companies.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Laboratorios Sanfer: Major Mexican pharmaceutical company producing generics, OTC, and specialty pharmaceuticals with national distribution across pharmacy chains. Operates in the same competitive set as Quimpharma in Mexican generics.
• Laboratorios Liomont: Mexican pharmaceutical laboratory founded in 1935, manufacturing generic prescription, OTC, and consumer health products with national pharmacy distribution. Comparable to Quimpharma as a similarly-positioned Mexican pharma lab with multi-category product portfolio.
• PiSA Farmacéutica: Mexican pharmaceutical group with manufacturing, distribution, and hospital supply operations. Comparable as a vertically-integrated domestic pharma manufacturer competing for pharmacy chain shelf space in Mexico.
• Laboratorios Silanes: One of Mexico's largest generic pharmaceutical manufacturers, producing prescription and OTC medications with national distribution. Highly comparable to Quimpharma in business model (generic manufacturing + pharmacy channel) though at substantially larger scale.
• Laboratorios Chinoin: Mexican pharmaceutical manufacturer (Bayer subsidiary) producing prescription, OTC, and consumer health products. Competes with Quimpharma in pharmacy channel across multiple therapeutic categories.
• Grupo SOMAR: Mexican pharmaceutical holding company with multiple manufacturing labs (including Maver, Atlantis) producing generics, dermatology, and consumer health products. Direct competitor in Mexican generics and dermocosmetic categories.

Broad incumbents

• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with significant Mexican market presence. Relevant incumbent peer competing in the same generics category across Mexican pharmacy chains.
• Genomma Lab Internacional: Leading Mexican OTC and personal care pharmaceutical company with extensive brand portfolio. Comparable as Mexican pharma with multi-category OTC + dermocosmetic presence, though at much larger scale and with consumer-brand focus.
• Bayer de México: Mexican subsidiary of global pharma major with diverse prescription, OTC, and consumer health portfolio including dermocosmetics (e.g., Bepanthen). Competitor in pharmacy channel across multiple product categories where Quimpharma operates.
• Apotex: Canadian-based generic pharmaceutical manufacturer with global operations. Relevant broader incumbent for generic pharma manufacturing capabilities, though operating primarily in Canada/US markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/QuimpharmaLab
• LinkedInlinkedin.com/company/laboratoiros-quimpharma-s.a.-de-c.v.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoiros Quimpharma, s.a. de c.v.